Spero closes $30M series B round
Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) secured $30 million in a tranched series B round from existing investors Atlas Venture, SR One, MRL Ventures, Lundbeckfond Ventures, the Kraft Group and...